DatasetName,FANCE_S(154) FANCE_S(180) FANCE_S(194) FANCE_S(204) FANCE_S(249),FANCE_S(210) FANCE_S(238) FANCE_S(247) FANCE_T(495)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5763559315436286,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5561665567011368,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.542280413160511,0.5042753091827183
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5370650504190048,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5541404945027222,0.4723916492902853
RKK2015_TNF-α/basal,0.5449682315546392,
JJ2018_Ratio H/M normalized pP2,0.5433006622039243,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.588348696140634,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5549118206025115,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5894946728230277,0.4615432154640625
FSO2013_Ratio M/L normalized Rep1___1,0.5550585056141957,
SAS2015_AZD/DMSO_Exp3,0.574971263767579,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6148615411161369,0.5268751825149935
WZ2023_Pu_010_30min,0.5361262977896835,0.4682197393034832
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5477158308021765,0.459443900042777
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6023077859154837,0.4604312991802987
JJ2018_Ratio H/L normalized___1,0.5588619805689774,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.5459688739929307,0.4953417395132617
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5436894746247705,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5810844692874048,0.4221279736237066
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5239217723145935,0.4626550393988863
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5280346813906551,0.45493592000126887
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5465674786787473,
WZ2023_Pu_025_30min,0.5248905498289644,0.45825742220244187
AH2018_SILAC_MR_2_X,0.5705550899789209,0.49443218869986894
HS2024_4_PD_T2,0.5467278166269095,0.4967863571651681
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5774748984485009,0.5529622250509016
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5450872145786114,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5525487285851153,0.47838444308745204
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5612728262783505,0.47499689858043453
HS2024_7_PD_T2,0.5592142993133645,0.46089649688500417
FSO2013_Ratio H/L normalized Rep1___1,0.5556066263909903,
AH2018_LFQ_1_C,0.5632308090632316,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.5462458711366011,0.48337521527234495
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5251519916931608,0.45974206853527316
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5632623404276138,0.47259533926301245
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5401068355239659,0.4096739648213519
FSO2013_Ratio H/L normalized Rep2,0.5870533026918648,
WZ2023_Pu_005_20min,0.5347456517713615,0.4565914913524903
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5550220647101194,0.4903216320094489
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5223084813535148,0.44765996611964187
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5678303360643676,0.4562222525690051
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5943343671701911,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.4666487620569144
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5917840474588335,0.5254372352516636
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5281196796853866,0.47178139617056797
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5469189276150557,
CK2022_1 200-1,0.553493459999349,0.4797345779180863
PG2020_Intensity Mock_10h_D,0.5312007725156114,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.4553183756684034
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5636405746835985,0.4683391202873328
RCJD2014_5min_1,0.5481408786399544,0.5356576608879638
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.5689661673540982,0.4849389432568574
CR2017_Ratio Replicate 3.3,0.5693882634081758,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.464775640233671
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.5811277634611401,0.5178933685008116
AH2018_LFQ_M_2_C,0.5730124638011386,0.47795448772748084
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5318236508924399,0.4720737625810272
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5872944791157729,0.5239320765233997
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5866477602124517,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5472501144063118,0.47720016237138585
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,0.4872507418258412
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5478121143788937,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.5675212986067246,0.49335347940847635
CF2017_EOC 3,0.543036497730798,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.4676422011340001
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5328800688557043,0.4467209143603558
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5391178278856541,
KS2014_Intensity N3,0.5419732788467546,0.41578847552263815
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5556090588749004,0.4806971467520156
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,
HS2024_8_PD_T1,0.5700029227386756,0.49049959365655765
JJ2018_Ratio H/L normalized pP2,0.5786171905558589,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5534811367430803,0.4336068451698208
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.5526091241238911,0.4960718787961076
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.5338744561209546,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5460925570053804,0.48730125732555735
AH2018_SILAC_M_3_X,0.5531861816576777,0.4796648001776363
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.549826052931408,0.45236113125762684
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6158081911072883,0.5272916027502412
HS2024_6_B_N1,0.5350067650459944,0.45987262693019115
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5500178222183132,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.5895011424609747,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5485135009096178,0.449921417616493
DL2023_control-1,,
AR2021_ALG 10 μM,0.5823937357373252,0.5211612760007739
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5424361451736195,0.47235955998583623
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5379590363653811,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.55237997964326,0.4708677767459265
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.583062037900633,
AH2018_SILAC_2_N,0.56068876929839,0.473329208526568
CK2022_11 200-1,0.532668967685882,0.4690546506073436
CK2022_12 200-1,0.5338958149989071,0.46700291799892646
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5304914193596892,0.46260908698489006
AH2018_TMTMS2_2_N,0.6051436158786767,0.47427353517289766
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.577947920492345,0.5146523741079689
KS2014_Intensity N4,0.5465561114114981,0.43960384464082786
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5422088177027293,
CK2022_14 200-1,0.5409261259345902,0.4756552823848958
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5754101252165005,0.49688641153259067
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5242277805850438,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5493089108003588,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.5560766508560344,0.44768761933387924
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5228342798909182,0.45603693125602546
CF2017_EOC 1,0.5491830197983425,
CK2022_3 200-1,0.551100738039236,0.47755873717674563
AH2018_LFQ_IT_3_C,0.5629890812010021,0.47437002002623707
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5402311124100593,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5806523779768203,0.4715285479125445
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.5231289694865552
HS2024_5_B_T1,0.5690345925647928,0.5121370622864323
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5588772596250104,0.5016996194416047
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5531920978856772,0.4797038074953889
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5402355488187233,
AR2021_ALG 1 μM,0.4953696309420387,0.49962335162354377
HS2024_4_B_T1,0.5776287074174478,0.4708487778260476
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.542414393262004,0.49626901788062305
CR2017_Ratio Replicate 3.2,0.5706081315413652,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,0.5371380013272082,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5395669110087468,0.47586958146180136
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.4217660666496403
CK2022_16 16-1,0.5466386687534666,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.539892703346614,0.46388409970084166
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5631556783958699,0.47255746041452784
HS2024_5_PD_T3,0.5968687862008515,0.517836748475477
AH2018_TMTMS3_3_X,0.5720824537810705,0.518862808221201
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.44316460005119196
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5409183776527167,
AH2018_SILAC_M_1_N,0.5620625404753109,0.4821220488044725
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5148492525992631,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5342471623760211,
RN2012_L13,0.537823067438619,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.49480577895694833
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.593127700574898,0.468495933331553
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.60550664392756,0.4713607502459869
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.601136432085448,0.4611107073277917
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.5502899153542149,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.649264341557532,0.5339349098108379
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5887482875637943,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.6174944295469842,0.4984363809266471
AH2018_LFQ_1_X,0.5405534671466758,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5670160784559268,0.4812379042660066
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.48283086676838616,0.4019491681837989
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5318170625645482,0.4631523149703309
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5160773552510902,0.4551919510607859
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.535973899108238,0.43526356839770225
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5807119138109818,0.49125805169997083
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5802834863922389,0.5177216004712898
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.5480841677220114,0.47837890533080346
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.4894957937581343,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.6145639538169856,0.44499728372624414
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5506889011236225,0.4773743052322179
SAS2015_PLX/AZD_Exp1,0.5379158430405805,0.5016861186499468
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5467300046916923,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5117415044006777,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5417322873198008,0.5145422121181242
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5589500346752582,0.4703445574611711
CK2022_7 200-1,0.5341525592091384,0.46765702078040766
CK2022_5 200-1,0.5353991803527938,0.4688473293780528
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5876878384513531,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5683732544582044,
AH2018_SILAC_MR_1_X,0.5461442189355983,0.4597401185271982
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5507168049347457,0.47737923571580243
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5386661680140493,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5459368859461874,
SAS2015_PLX/DMSO_Exp1,0.5646326174888927,0.5404740361854118
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.58316110353,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5878158863301819,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5820277624677455,
JJ2018_Ratio M/L normalized,0.5769155873040256,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5683256597132367,0.4778462908651235
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5469451867326878,0.4730621294070456
AH2018_SILAC_IT_1_X,0.5685145463914433,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5457796343530975,0.4572866234136319
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.5339696413902882,0.4594961704952924
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5507886347590204,0.4401841815093773
HS2024_4_I_N2,0.5677440321890161,0.48461506797292786
AH2018_TMTMS2_3_N,0.6030497478108738,0.4680653281025289
RN2012_H06,0.536763580055102,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5849723505419254,0.4791542948973656
WZ2023_Su_005_30min,0.5301158436209723,0.45877240749032583
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5544528150957813,
WZ2023_Su_025_10min,0.5307515520491404,0.46857995520130463
AH2018_LFQ_IT_4_X,0.5525191166973431,0.4783015245146124
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5370862403286304,0.4575557523326777
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.5484328916931961,
EP2017_Pervanadate R#1 log2 ratio,0.5777864714743003,0.43273994847131014
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5903560001153207,0.48443421403414827
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.46488160586006605,0.4569644060944177
RN2012_L10,,
PG2020_Intensity 4h_C,0.4675349658316931,
EP2017_Mitotic R#3 normalized log2 ratio,0.5487643322883182,0.45623315985996943
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5686554724767984,
HS2024_4_B_T3,0.5826102552677365,0.4938514087037857
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5845633244833944,0.5038131956793166
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5785641486933594,
HS2024_8_I_T2,0.5793509838150538,0.5039719533223798
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5599524552663666,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5368115781876859,0.4733910553454783
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5646261237110292,0.4739563341413915
GF2025_P9_Sph,,
CK2022_6 200-1,0.5381169620058466,0.47256188694078927
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5790807118566564,0.5183564918446593
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5477620638991858,0.4746008949114873
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5830168579678855,0.45043650164951365
SAS2015_AZD/DMSO_Exp1,0.5669691205940377,0.5395307424827122
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.5274352190877987,0.48669683987429163
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.5597550923123228,0.49956822796702505
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5374897772543245,0.4715260500889048
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5580002322848585,0.5020581522696864
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5457659414632776,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5901339375944332,0.40806875073580257
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5630927997442703,0.47437462128844204
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5762033181195177,0.47134944419377317
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.5544341121586067,0.4438976353776143
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5874225674319561,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.57348884550178,0.5396847400860744
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5719847816508679,0.4626390879654827
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5328374515442286,0.43602205888793166
ZCP2016_Ratio H/L Rep 1,0.5193774081662197,0.49393196860309524
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5606563699344288,0.4998536650554972
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5531062421732619,0.5343081366131556
HS2024_8_PD_T2,0.5530193567179794,0.5222964899750727
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5351945814608332,0.46771938649073197
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5583644497819702,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5664443384194628,0.50286297625352
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.6068189840412559,0.46787124087020454
HS2024_3_PD_T3,0.556534364563354,0.49500361623928907
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5563909095255217,0.4621859727317167
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5390734525524647,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5599305812302651,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5673873187539196,0.4813648945397436
PG2020_Intensity Mock_10h_B,0.5359723835563738,
WZ2023_Su_025_30min,0.5295008125496269,0.4632384612210086
AH2018_LFQ_4_N,0.5667934200008841,0.4670659795270983
CR2017_Ratio Replicate 1.2,0.5646490670368423,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5222984445320654,0.4782117200326883
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.562717197997208,0.48553432020520326
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5696535965001643,0.4842761009480378
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5703151256644803,0.5059142791177721
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5599367290408443,0.4708634820670785
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.587381285903206,0.47861918211032906
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.571266980095458,0.476060954277934
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.5718006285872099,0.4830267766567371
PG2020_Intensity 2h_B,0.5245620453004638,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5443703773158163,0.48198335290877525
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5541134482929457,0.4724571925117981
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5458585916230925,0.4723288299573795
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5491463880505727,
CR2017_Ratio Replicate 2.4,0.5407756940398747,0.4570484281450273
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5410177864372365,
AH2018_LFQ_3_N,0.5649853242449152,0.45429475236637024
RKK2015_TNF-α/IKKb,0.5400750025205985,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5152516926541578,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5587905277158468,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5562780055454691,0.4852005224804813
WZ2023_Su_025_20min,0.5346416129703118,0.4612559526197004
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5531025217313197,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5454228062814213,0.4901846327276732
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5781996651194843,0.42153400456513745
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5470715909338036,0.4258565941823633
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5424297592970339,0.49581188568681395
AH2018_LFQ_M_4_C,0.5548553216957279,0.4495382091008959
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5734071954297529,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5322876929062668,0.4669228220555512
HS2024_8_PD_T3,0.559806748596822,0.5246495536615886
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.44926434155753203,0.46783237960971447
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5344710957006517,0.4606457914310424
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5577893117628692,0.4961347519403905
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6076922595246407,0.47034208833875385
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5801372753878334,0.5103712792049101
HS2024_8_I_N2,0.5281850630343998,0.4885606686023015
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5627416988494097,0.4767473188302799
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.543158283771492,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5561178387874537,0.45096905122346004
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5401599269861278,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.5544297995748103,0.48432414519738215
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5324497896095133,0.4663327458290498
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5239876012081571,0.45544787968152994
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.4501674415425131
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5742748124037074,0.5181871852299789
HS2024_6_I_T1,0.5420558420425614,0.48073826096988737
HS2024_5_B_T3,0.5959486510003502,0.4937872936142036
JJ2018_Ratio H/M normalized pP1___1,0.5473644574094211,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5842973637742515,0.5124314737682731
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5548968878687326,0.49315350492914517
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5412830034089449,0.4541514190450732
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5347950742828076,0.4653794932111753
KS2014_Intensity C2,0.5721854906758196,0.47404517994030426
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5298228881473314,0.463859628225254
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5301482701384641,0.46357683024812724
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5882874023766116,0.5002495681248217
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,0.5561493357892257,
RKK2015_TNF-α/TNF-α+SC-514,0.581677581493721,
CR2017_Ratio Replicate 2.5,0.5465017090701162,0.46884808716678056
HS2024_3_I_T3,,0.48237133854731673
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5479084394765896,0.5077699283145581
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.465351943923862,0.45714867600589265
RKK2015_SC-514/basal,0.5410176442079824,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5378773379667777,0.4706642030399101
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5704793265753081,0.49870664398034587
KS2014_Intensity N1,0.547082458937316,0.4524371401809382
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5746231627355426,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5347836358603836,0.4928071726318218
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.569812191136856,0.49448757190368314
JJ2018_Ratio H/M normalized___1,0.5365877416564626,
RCJD2014_15min_2,0.6103810122946853,0.4921852909472977
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5751578548855718,0.5012289213417033
HS2024_5_I_N1,0.5808333170197788,0.5023703413563365
HS2024_6_I_N1,0.5329709454642362,0.4173291063885883
AR2021_KD 48h,0.5915172254783637,0.4963525977005373
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5610015782703657,0.5044760767101136
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5329504623130095,0.46255069736819193
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5473682942599162,0.4944473382652109
AH2018_LFQ_M_2_X,0.5768100288047358,0.4905856083260303
AH2018_LFQ_IT_4_N,0.5472025856930277,0.47717193138427083
CK2022_15 200-1,0.5394905109027586,0.4760904160350171
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5367125949005302,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.551067571748143,0.4781185366809883
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5349032901710264,0.46261606589801074
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5804619178928683,0.4341350381399671
HS2024_8_B_T3,0.5035197118453596,0.44944826029333707
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.5262647022468985,0.44082621162203683
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5486724097135034,0.5554340258930948
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5801431505049843,0.48736072634224753
KS2014_Intensity C1,0.5528037474893217,0.509884642814838
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.5515571424230681,0.478928353367012
RKK2015_TNF-α+IKKb/TNF-α,0.5548343491125153,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5636291837764034,0.47591316580645104
AH2018_SILAC_M_2_X,0.5620376872611402,0.47134733760587566
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5348856469082082,0.46095826042865007
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5490256535384578,
AH2018_LFQ_M_3_N,0.5695797158055178,0.44349341168761003
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6048759718959358,0.4809070778648517
CK2022_15 16-1,0.549662699984694,
CK2022_3 16-1,0.544695881352942,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5486523801662946,0.49921540637626194
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,0.5306525338116961,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5497615726124325,0.5298772550651399
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5530946155269676,0.4699260081617173
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5004709560091731,0.5047063434987905
CF2017_EOC 2,0.5402802524437585,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5555956706541483,0.4807336953186849
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5369094739440059,0.4995491305811367
CK2022_6 16-1,0.5366701111349668,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5751556668687512,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6053068124367549,0.4718993455506706
AR2021_L41 1 μM,,0.49065659890774876
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5993279085381188,0.45952941816267084
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5712921580968218,0.4719314503875444
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5314953012007432,0.5323817163229899
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5236168481199999,0.46265063807669804
SAS2015_PLX/DMSO_Exp3,0.5386271322047314,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5580860107661237,0.47696089427087474
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5519669774994072,0.47641971248092213
WZ2023_Pu_025_10min,0.5315783625252205,0.4578412230423065
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5377962780328969,0.5286126273718506
FSO2013_Ratio M/L normalized Rep3___1,0.5757827170189056,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5501000857468221,
CF2017_EOC 4,0.5197186029829541,
JJ2018_Ratio H/L normalized pP1___1,0.5420795764151956,
WZ2023_Pe_010_30min,0.5328382648274499,0.4616864974285547
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5605649697538009,0.4732791554091954
KS2014_Intensity C6,0.5695761238859871,0.48491916535284585
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,0.5473111539500659,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5511468378666617,0.4802492091938607
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5655975965454587,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5886360232613552,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5506374721770654,0.4997433479279534
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.532229354227162,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5058030620824512,0.44138503783699035
PG2020_Intensity CT_B,0.5361623274375182,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5418790532263272,0.4951952582778746
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5363518513054968,0.5081067349067764
AH2018_LFQ_3_C,0.5526559827713079,0.45830048167632875
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5701670353451138,0.462819395189813
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5769089629835229,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5475572083214055,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5564901331371477,0.5052146064518065
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.551531369963145,0.464341235843857
AH2018_TMTMS2_1_X,0.6010819174068511,0.4569372309748764
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.5223976768535933,0.4688650110277034
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5389302633585317,0.44027769927553784
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.552836929879274,0.5383554391479324
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.5718068599843453,0.47959910927577115
AH2018_SILAC_1_X,0.5544517567232237,0.48441326954020714
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5726894344678467,0.4982849593660034
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5412700015219072,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5156752001870997,0.4549879938699109
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5718126268576486,0.5074470402636042
SAS2015_PLX/AZD_Exp3,0.5118397571431094,
EP2017_Pervanadate R#2 log2 ratio,0.587192144690188,0.4065869631212301
AS2011_Ratio H/L Normalized RNAi_2_1,,
